Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,699 | 26,374 | 18,101 | 4,426 | 8,859 |
| Marketable Securities | 60,065 | 69,513 | 76,669 | 87,469 | 92,621 |
| Receivables | 4,494 | 2,658 | 2,602 | 1,208 | 1,592 |
| Income taxes - deferred | 11,123 | 11,183 | N/A | N/A | N/A |
| TOTAL | $107,975 | $111,678 | $99,349 | $94,378 | $104,713 |
| Non-Current Assets | |||||
| PPE Net | 1,803 | 1,551 | 1,377 | 1,077 | 1,121 |
| Investments And Advances | 41,003 | 41,700 | 7,184 | 14,267 | 10,703 |
| Other Non-Current Assets | 4,634 | 4,585 | 436 | 436 | 436 |
| TOTAL | $47,440 | $47,836 | $8,997 | $15,780 | $12,260 |
| Total Assets | $155,415 | $159,514 | $108,346 | $110,158 | $116,973 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,874 | 1,284 | 2,041 | 840 | 1,481 |
| Accrued Expenses | 2,872 | 2,984 | 2,327 | 1,723 | 3,035 |
| TOTAL | $4,746 | $4,268 | $4,419 | $2,568 | $4,526 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 0 | 51 | 5 | 10 |
| Other Non-Current Liabilities | 2,015 | 2,293 | 2,212 | 2,010 | 1,979 |
| TOTAL | $2,015 | $2,293 | $2,212 | $2,010 | $1,979 |
| Total Liabilities | $6,761 | $6,561 | $6,631 | $4,578 | $6,505 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,604 | 18,583 | 18,538 | 18,363 | 17,962 |
| Common Shares | 188 | 188 | 187 | 182 | 181 |
| Retained earnings | -73,012 | -67,970 | -118,023 | -112,820 | -107,450 |
| Other shareholders' equity | -102 | -6 | 59 | 30 | -4 |
| TOTAL | $148,654 | $152,953 | $101,715 | $105,580 | $110,468 |
| Total Liabilities And Equity | $155,415 | $159,514 | $108,346 | $110,158 | $116,973 |